View Cart (0 items)

Items Tagged with 'Indian pharmaceutical industry'


Health Canada raises concerns over two Indian pharmaceutical facilities

Health Canada has asked Canadian importers to quarantine drug products manufactured at two facilities in India as a precautionary measure.
Read More

Indian drug maker faces court action over alleged patent infringement

Indian pharmaceutical research company Aurobindo Pharma is facing legal action from three large international competitors that have accused the company of patent infringement.
Read More

New FDA import ban hits Indian drug-making industry

The FDA's campaign against substandard pharmaceutical products manufactured in India is continuing with a new import ban, this time imposed on drugs produced at a Bangalore facility owned and operated by Canadian company Apotex Inc.
Read More

Indian pharmaceutical firms braced for effect from US drug supply market mergers

The U.S. pharmaceutical supply chain is predicted to go through a stage of consolidation which will have an impact on the Indian drug manufacturing market, according to industry experts.
Read More

FDA sends warning letter to Indian drug maker

Mumbai-based pharmaceutical firm Wockhardt Ltd has announced that it has received a warning letter from the U.S. Food and Drug Administration (FDA) regarding the import alert on production originating from the company's Waluj facility in India.
Read More